The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127192561 12719256 1 I 20160825 20160907 20160907 EXP CN-TAKEDA-2016MPI007767 TAKEDA LI X, ZHONG Y, HU Y, ZHANG J, AN N, CHEN S.. EFFECTS OF BORTEZOMIB COMBINED WITH METHYLPREDNISOLONE IN TREATMENT OF 33 CASES OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA.. JOURNAL OF EXPERIMENTAL HEMATOLOGY. 2011;19(4):987-990 0.00 Y 0.00000 20160906 OT CN CN

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127192561 12719256 1 PS VELCADE BORTEZOMIB 1 Unknown UNK Y 21602 INJECTION
127192561 12719256 2 SS METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Unknown UNK Y 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127192561 12719256 1 Plasma cell myeloma
127192561 12719256 2 Plasma cell myeloma

Outcome of event

Event ID CASEID OUTC COD
127192561 12719256 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127192561 12719256 Epilepsy
127192561 12719256 Fatigue
127192561 12719256 Gastrointestinal disorder
127192561 12719256 Hepatic function abnormal
127192561 12719256 Herpes zoster
127192561 12719256 Hypokalaemia
127192561 12719256 Hypoxic-ischaemic encephalopathy
127192561 12719256 Lung infection
127192561 12719256 Neuropathy peripheral
127192561 12719256 Neurotoxicity
127192561 12719256 Pancytopenia
127192561 12719256 Pneumonia
127192561 12719256 Thrombocytopenia
127192561 12719256 Upper respiratory tract infection
127192561 12719256 Urinary tract infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found